• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Roles of Toll like receptor in the development of autoimmune diseases

Research Project

Project/Area Number 14570432
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 内科学一般
Research InstitutionYokohama City University School of Medicine

Principal Investigator

MITSUHIRO Takeo  Yokohama City University Graduate School of Medicine and School of Medicine, Departments of Internal Medicine and Clinical Immunology, Associate Professor, 医学部, 講師 (50236494)

Co-Investigator(Kenkyū-buntansha) SUZUKI Noboru  St.Marianna University School of Medicine, Departments of Immunology and Medicine, Professor, 医学部, 教授 (40235982)
UEDA Atsuhisa  okohama City University Graduate School of Medicine and School of Medicine, Departments of Internal Medicine and Clinical Immunology, Associate Professor, 医学部, 講師 (60295483)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥2,900,000 (Direct Cost: ¥2,900,000)
Fiscal Year 2003: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2002: ¥1,700,000 (Direct Cost: ¥1,700,000)
KeywordsBehcet's disease / toll like receptor / tumor necrosis factor / NK cell / heat shock protein / heme oxygenase-1 / 炎症性サイトカイン
Research Abstract

It has been discussed that microbial pathogens is implicated in the development of autoimmune diseases such as Behcet's disease. One of the putative pathogenic antigens is 65 kD of heat shock protein (HSP) which are conserved during evolution and has a potent immunostimulatory property, leaking to cross reaction between microbial and host HSP. In addition, HSP is one of the ligands against toll like receptor (TLR) 4. We investigated involvement immune system, especially TLR in patients with Behcet's disease.
We monitored cytokine profile by using ELISPOT techniques during anti-tumor necrosis factor(TNF)-alfa monoclonal antibody therapy or Behcet's disease patients with refractory uveitis. The results revealed that anti-TNF-alfa mAb therapy significantly reduced circulating TNF-alfa producing cells, which was closely associated with clinical remission (Misumi M, Takeno M, et al. Cytokine 24(5):210, 2003) Next, we found abnormal expression of killer inhibitory receptor in NK cells from the patients (Takeno M, et al. Rheumatol Int, (in press)). These findings indicated that innate immune system is impaired in the disease.
We examined mRNA expression of TLR 2,4, and 9 in peripheral mononuclear cells and pleomorphic nuclear cells by real time PCR technique, but did not find any abnormalities in patients with Behcet's disease. We next studied expression of heme oxygenase-1, which has anti-inflammatory properties and increased in patients with adult still's disease. The data showed that high levels of HO-1 protein and mRNA were expressed in pleomorphic nuclear cells (neutrophils) from patients with Behcet's disease when compared with normal controls. The data suggest that the regulatory system of inflammation is impaired in the disease.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (43 results)

All Other

All Publications (43 results)

  • [Publications] Takeba, Y., et al.: "Txk, a member of non-receptor tyrosine kinase of Tec family, acts as a Th1 cell specific transcription factor and regulates IFN-gamma gene transcription."J.Immunol.. 168. 2365-2370 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Kashiwakura, J., et al.: "Evidence of autophosphorylation in Txk : Y91 is an autophosphorylation site."Biol.Pharmaceutical Bulletin.. 25. 718-721 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Wakisaka S, et al.: "Fas ligand expression in lymphocytes in patients with Behcet's disease."Int Arch Allergy Immunol.. 129. 175-180 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nagafuchi H, et al.: "Aberrant expression of Fas ligand on anti-DNA autoantibody secreting B lymphocytes in patients with systemic lupus erythematosus : "immune privilege"-like state of the autoreactive B cells."Clin Exp Rheumatol. 20. 625-631 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Miyagi, T., et al.: "Flk1 positive cells derived from mouse embryonic stem (ES) cells reconstitute hematopoiesis in vivo in SCID mice."Exp Hematol.. 30. 1444-1453 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Suzuki N, et al.: "Bilateral subdural effusion in a patient with neuro-Behcet's disease."Ann Rheum Dis. 62. 374-375 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nagafuchi H, et al.: "Preferential expression of B7.2(CD86),but not B7.1(CD80),on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus."Clin Exp Rheumatol.. 21. 71-77 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Misumi M, et al.: "Cytokine production profile in patients with Behcet's disease treated with infliximab."Cytokine. 24. 210-218 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takeno, M.et al.: "Behcet's disease and inflammtory bowel diseases."Internal Med.. 43. 172-173 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takeno M, et al.: "Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behcet's disease."Rheumatol Int.. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 武半優子, 他: "ヒトTh1細胞特異的Tec familyチロシンリン酸化酵素、Txkの機能解析と各種自己免疫疾における発現"炎症・再生. 22. 475-479 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Suzuki N, Takeno M, et al.: "Imunology of Behcet's Desease."Swets and Zeitlinger, Lisse, Netherlands. 178 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 坂根剛, 岳野光洋, 他: "NEW薬理学(改訂第4版)"南江堂、東京. 670 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 岳野光洋, 他: "year note 2003"メディックメディア、東京. (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 岳野光洋, 他: "新臨床内科学(第8版)"医学書院、東京. 2045 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 松田隆秀, 他: "ベーチェット病ガイドブック-その概念・病態・診療の指針-"日本医学館. 126 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 岳野光洋: "内科学書第六版"中山書店、東京. 2329 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 岳野光洋, 他: "year note 2004"メディックメディア、東京. (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takeba, Y., Nagafuchi, H., Takeno, M., Kashiwakura, J., Suzuki, N.: "Txk, a member of non-receptor tyrosine kinase of Tec family, acts as a Th1 cell specific transcription factor and regulates IFN-gamma gene transcription."J.Immunol.. 168(5). 2365-2370 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Kashiwakura, J., Suzuki, N., Takeno, M., Itoh, S., Oku, T., Sakane, T., Nakajin, S., Toyoshima, S.: "Evidence of autophosphorylation in Txk : Y91 is an autophosphorylation site."Biol.Pharmaceutical Bulletin.. 25(6). 718-721 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Wakisaka S, Takeda Y, Mihara S, Takeno M, Yamamoto S, Sakane T, Suzuki N.: "Aberrant Fas ligand expression in lymphocytes in patients with Behcet's disease."Int Arch Allergy Immunol.. 129(2). 175-80 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nagafuchi H, Wakisaka S, Takeda Y, Takeno M, Sakane T, Suzuki N.: "Aberrant expression of Fas ligand on anti-DNA autoantibody secreting B lymphocytes in patients with systemic lupus erythematosus : "immune privilege"-like state of the autoreactive B cells."Clin Exp Rheumatol.. 20(5). 625-31 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Miyagi, T., Takeno, M., Nagafuchi, H., Takahashi, M., Suzuki, N.: "Flk1 positive cells derived from mouse embryonic stem (ES) cells reconstitute hematopoiesis in vivo in SCID mice."Exp Hematol. 30(12). 1444-53 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Suzuki N, Takeno M, Inaba G.: "Bilateral subdural effusion in a patient with neuro-Behcet's disease."Ann Rheum Dis. 62(4). 374-5 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nagafuchi H, Shimoyama Y, Kashiwakura J, Takeno M, Sakane T, Suzuki N.: "Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus."Clin Exp Rheumatol.. 21(1). 71-7 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Misumi M, Hagiwara E, Takeno M, Takeda Y, Inoue Y, Tsuji T, Ueda A, Nakamura S, Ohno S, Ishigatsubo Y.: "Cytokine production profile in patients with Behcet's disease treated with infliximab."Cytokine. 24(5). 210-8 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Suzuki N, Shimoyama Y, Nagafuchi H, Takeda Y, Takeno M, Sakane T: "Autoimmunity in Behcet's disease."Immunology of Behcet's Desease.(Ed by Zierhut M and Ohno S)(Swets and Zeitlinger, Lisse, Netherlands). 81-86 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takeno M, Shimoyama Y, Nagafuchi H, Suzuki, N, Sakane T: "Neutrophil hyperactivity in Behcet's disease."Immunology of Behcet's Desease.(Ed by Zierhut M and Ohno S)(Swets and Zeitlinger, Lisse, Netherlands). 97-101 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takeno, M., Ishigatsubo, Y.: "Behcet's disease and inflammtory bowel diseases."Internal Med.. 43(3). 172-173 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takeno M, Shimoyama Y, Kashiwakura JI, Nagafuchi H, Sakane T, Suzuki N.: "Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behcet's disease."Rheumatol Int. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Suzuki N, et al.: "Bilateral subdural effusion in a patient with neuro-Behcet's disease"Ann Rheum Dis. 62(4). 374-375 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Nagafuchi H, et al.: "Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus"Clin Exp Rheumatol. 21(1). 71-77 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Misumi M, et al.: "Cytokine production profile in patients with Behcet's disease treated with infliximab"Cytokine. 24(5). 210-218 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Takeno M, et al.: "Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behoet's disease"Rheumatol Int.. (in press).

    • Related Report
      2003 Annual Research Report
  • [Publications] Takeno M, et al.: "Behcet's disease and inflammtory bowel diseases"Internal Med. (in press).

    • Related Report
      2003 Annual Research Report
  • [Publications] Suzuki N, et al.: "Imunology of Behcet's Desease (Ed by Zierhut M and Ohno S)"Autoimmunity in Behcet's disease. 6 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Takeno M, et al.: "Imunology of Behcet's Desease (Ed by Zierhut M and Ohno S)"Neutrophil hyperactivity in Behcet's disease. 5 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Takeba, Y., Nagafuchi, H., Takeno, M., Kashiwakura, J., Suzuki, N.: "Txk, a member of non-receptor tyrosine kinase of Tec family, acts as a Th1 cell specific transcription factor and regulates IFN-gammma gene transcription"J. Immunol.. 168(5). 2365-2370 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Kashiwakura, J., Suzuki, N., Takeno, M., et al.: "Evidence of autophosphorylation in Txk : Y91 is an autophosphorylation Site"Biol. Pharmaceutical Bulletin.. 25(6). 718-721 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Wakisaka S, Takeba Y, Mihara S, Takeno M, et al.: "Aberrant Fas ligand expression in Lymphocytes in patients with Behcet's disease"Int. Arch. Allergy Immunol.. 129(2). 175-180 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Nagafuchi H, Wakisaka S, Takeba Y, Takeno M, Sakane T, Suzuki N.: "Aberrant expression of Fas ligand on anti-DNA autoantibody secreting B lymphocytes in patients with systemic lupus erythematosus : "immune privilege"-like state of the autoreactive B cells"Clin. Exp. Rheumatol.. 20(5). 625-631 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Miyagi, T., Takeno, M., Nagafuchi, H., Takahashi, M., Suzuki, N.: "Flk1 positive cells derived from mouse embryonic stem (ES) cells reconstitute hematopoiesis in vivo in SCID mice"Exp. Hematol.. 30(12). 1444-1453 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Takeno M, Shimoyama Y, Nagafuchi H, Suzuki, N, Sakane T: "Imunology of Behcet's Desease"Swets and Zeitlinger, Lisse, Netherlands(in press).

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi